Program Overview
The demand for psychedelic-assisted psychotherapy is rapidly increasing across Canada, urging the necessity for trained prescribers to support medical access. TheraPsil’s specialized MDMA Prescriber Training Program, designed by prescribers for prescribers, is a half-day, online training that equips healthcare professionals to understand the safety and efficacy of psychedelic treatments.
Our training goal is to fully prepare our graduates to safely and effectively apply for psilocybin access for clients under Canada’s Special Access Program (SAP). TheraPsil will then connect trained prescribers with treatment teams of therapists who have completed TheraPsil’s Fundamentals of MDMA-Assisted Psychotherapy Training Program so they can work together to best support patients through all aspects of psilocybin treatment.
Discover our unique curriculum and learn more about the program content here.
Who Can Benefit from This Training?
TheraPsil invites prescribing medical professionals to join our MDMA Prescriber Training Program, aimed at supporting patients through psychedelic therapies. Explore the entrance and graduation requirements.
Certificates & Professional Designations
Upon acceptance into our program, professionals become TheraPsil Affiliates, committing to completing the prescriber training program. Learn about all certificates and professional designations for the Prescriber Training Program.
When and Where is the Next Training?
TheraPsil offers quarterly sessions for MDMA Prescriber Training. Our next sessions will be hosted in Fall & Winter 2024, dates to be announced. Be sure to apply below and stay tuned for upcoming dates via TheraPsil’s monthly newsletter.